Barclays’s TherapeuticsMD TXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-63
Closed 4282
2023
Q4
$0 Buy
+63
New ﹤0.01% 4338
2022
Q3
Sell
-4,000
Closed -$40K 4833
2022
Q2
$40K Buy
4,000
+2,542
+174% +$25.4K ﹤0.01% 3822
2022
Q1
$28K Sell
1,458
-8,007
-85% -$154K ﹤0.01% 4218
2021
Q4
$168K Buy
9,465
+6,225
+192% +$110K ﹤0.01% 2874
2021
Q3
$121K Buy
+3,240
New +$121K ﹤0.01% 3159
2021
Q2
Sell
-6,134
Closed -$411K 4223
2021
Q1
$411K Buy
6,134
+4,441
+262% +$298K ﹤0.01% 2759
2020
Q4
$103K Sell
1,693
-486
-22% -$29.6K ﹤0.01% 2966
2020
Q3
$171K Buy
2,179
+2,077
+2,036% +$163K ﹤0.01% 2805
2020
Q2
$7K Buy
102
+101
+10,100% +$6.93K ﹤0.01% 3677
2020
Q1
$0 Sell
1
-4,679
-100% ﹤0.01% 3915
2019
Q4
$566K Buy
4,680
+2,719
+139% +$329K ﹤0.01% 2621
2019
Q3
$355K Buy
+1,961
New +$355K ﹤0.01% 2792
2019
Q2
Sell
-2,480
Closed -$604K 4434
2019
Q1
$604K Buy
+2,480
New +$604K ﹤0.01% 2495
2018
Q4
Sell
-4
Closed -$1K 4387
2018
Q3
$1K Buy
+4
New +$1K ﹤0.01% 4251
2018
Q2
Sell
-746
Closed -$182K 4388
2018
Q1
$182K Buy
746
+744
+37,200% +$182K ﹤0.01% 2890
2017
Q4
$1K Sell
2
-70
-97% -$35K ﹤0.01% 4030
2017
Q3
$19K Buy
72
+45
+167% +$11.9K ﹤0.01% 3225
2017
Q2
$8K Sell
27
-349
-93% -$103K ﹤0.01% 3471
2017
Q1
$135K Buy
376
+329
+700% +$118K ﹤0.01% 2706
2016
Q4
$14K Sell
47
-339
-88% -$101K ﹤0.01% 3190
2016
Q3
$132K Buy
386
+384
+19,200% +$131K ﹤0.01% 2329
2016
Q2
$1K Hold
2
﹤0.01% 3472
2016
Q1
$1K Sell
2
-1,394
-100% -$697K ﹤0.01% 3337
2015
Q4
$698K Buy
1,396
+1,383
+10,638% +$692K ﹤0.01% 1522
2015
Q3
$3K Sell
13
-36
-73% -$8.31K ﹤0.01% 3431
2015
Q2
$17K Sell
49
-22
-31% -$7.63K ﹤0.01% 3052
2015
Q1
$21K Sell
71
-52
-42% -$15.4K ﹤0.01% 3092
2014
Q4
$25K Buy
123
+52
+73% +$10.6K ﹤0.01% 3342
2014
Q3
$14K Buy
71
+37
+109% +$7.3K ﹤0.01% 3589
2014
Q2
$7K Sell
34
-251
-88% -$51.7K ﹤0.01% 3797
2014
Q1
$85K Sell
285
-276
-49% -$82.3K ﹤0.01% 2870
2013
Q4
$140K Buy
561
+399
+246% +$99.6K ﹤0.01% 2844
2013
Q3
$16K Buy
162
+80
+98% +$7.9K ﹤0.01% 3549
2013
Q2
$12K Buy
+82
New +$12K ﹤0.01% 3844